Core Diagnostics

Expanding commercial availability of DetermaRx to India, Middle East, Africa. DetermaRx is Oncocyte’s treatment stratification…

There will be dedicated technicians, pathologists for COVID-19 testing with turnaround-time of same day for results

Cancer has emerged as an alarming cause of morbidity and mortality in India. According to The National Centre for Disease…

Healthcare experts share their views and insights on the impact and implications of Budget 2020

Zoya Brar, Founder and CEO, CORE Diagnostics shares what drives her, how she handles work and what are the changes she has…

The government needs a comprehensive regulatory framework and a strong intent to fight the mushrooming of fake path labs in the…

Highlights Big data matters because an average hospital generates 600 Tbytes per year. In between 2020 to 2030 healthcare…

Zoya Brar, MD and Founder, Core Diagnostics speaks to Prathiba Raju about the seven year journey of Core Diagnostics and about the…

The service will ensure best clinical intervention to improve outcomes in several chronic and generic kidney diseases including…